ChartMill assigns a Buy % Consensus number of 80% to SBBP. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-05-25 | JMP Securities | Downgrade | Outperform -> Market Perform |
| 2021-05-25 | Craig-Hallum | Downgrade | Buy -> Hold |
4 analysts have analysed SBBP and the average price target is 5.1 null. This implies a price increase of 155% is expected in the next year compared to the current price of 2.
The consensus rating for Strongbridge Bio Ord (SBBP) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.